Results for tag: "Anagrelide"

Anagrelide is an oncology drug used to treat thrombocythemia, a condition characterized by an abnormally high number of platelets in the blood. It works by reducing the production of platelets in the bone marrow, thereby reducing the risk of thrombosis. Anagrelide is available in both oral and injectable forms, and is typically used in combination with other drugs such as hydroxyurea. It is also used to reduce the risk of thrombosis in patients with essential thrombocythemia. Anagrelide is a relatively new drug, and is not widely used in the oncology market. However, it has been shown to be effective in treating thrombocythemia, and is increasingly being used in combination with other drugs to reduce the risk of thrombosis. Some companies in the Anagrelide market include Novartis, Teva Pharmaceuticals, and Mylan. Show Less Read more